BSE filing, NSE: DHANUKA. Summary written from the filing by ALFA Finder's alert engine.
Dhanuka Agritech Ltd: key numbers
- Share price
- ₹983.00
- Market cap
- ₹4,431 Cr
- Revenue (annual)
- ₹2,020 Cr
- Net profit (annual)
- ₹287.2 Cr
- P/E (TTM)
- 15.6×Sector 34.1×
- Promoter holding
- 69.81%+0.00% QoQ
- FII holding
- 1.59%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhanuka Agritech Ltd
All →Dhanuka Agritech Earnings Call Transcript: Key Takeaways
Dhanuka delivered resilient 9.91% revenue growth despite a 13% monsoon deficit, driven by a strong insecticide performance in North India.
- Call
- Guides 9% growth
Dhanuka Agritech Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 657.51 Cr (+9.9% YoY), EBITDA Rs 152.97 Cr (+11.9%), PAT Rs 109.22 Cr (+16.2%). Margins expanded YoY despite a weak monsoon-hit sector.
Dhanuka Agritech Q2 FY27 Results: Net Profit ₹109.2 Cr, Up 16.2% YoY
Dhanuka Agritech Ltd reported revenue from operations of ₹657.5 Cr (+9.9% YoY) and net profit of ₹109.2 Cr (+16.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹109.2 Cr · +16.2% YoY
Dhanuka Agritech Board Meeting Date
Dhanuka Agritech Ltd notified exchanges of a board meeting on 30 October 2026 to consider Q2 and half-year unaudited financial results. The notice is a future meeting intimation with no decision yet taken.
Dhanuka Agritech Management Change
Dhanuka Agritech Limited announced the resignation of Umesh Verma, General Manager-Procurement, effective October 15, 2026. The departure is to pursue other career opportunities.
Dhanuka Agritech Product Launch
Dhanuka Agritech has launched a new herbicide product, Tembotrax, for the domestic Indian market. This herbicide controls broadleaf and grassy weeds in Maize and Sugarcane crops.
Other results update announcements
All →Narayana Hrudayalaya Results Update
Narayana Hrudayalaya reported Q2 FY27 consolidated revenue of Rs 28,440 Mn, up 73% YoY. PAT rose 16.6% to Rs 3,012 Mn, with the UK acquisition boosting revenue.
Corona Remedies Results Update
Corona Remedies released unaudited Q2 and H1 FY27 results highlights via press release. Revenue grew 22% year on year, with EBITDA and PAT also rising.
Acme Universal Safezone 9 Results Update
Acme Universal Safezone 9 reported H1FY27 revenue up 16.09% to ₹119.93 crore. EBITDA rose 54.62% and PAT turned to ₹7.02 crore profit.
Radiowalla Network Results Update
Radiowalla Network reported H1 FY27 revenue of ₹107.93 million, up 7% year-on-year. EBITDA rose to ₹8.16 million, with an 8% margin.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Advait Energy Transitions Results Update
Advait Energy reported Q2 FY27 consolidated revenue of ₹220.9 crore, up 40.8%, and PAT of ₹19.18 crore, up 88.5%. Its order book reached ₹1,574.8 crore.
- Order book
- ₹1,575 Cr